American Association for Cancer Research
Browse

Supplementary Methods from BRCA1 Deficiency Exacerbates Estrogen-Induced DNA Damage and Genomic Instability

Download (124.04 kB)
journal contribution
posted on 2023-03-30, 22:01 authored by Kienan I. Savage, Kyle B. Matchett, Eliana M. Barros, Kevin M. Cooper, Gareth W. Irwin, Julia J. Gorski, Katy S. Orr, Jekaterina Vohhodina, Joy N. Kavanagh, Angelina F. Madden, Alexander Powell, Lorenzo Manti, Simon S. McDade, Ben Ho Park, Kevin M. Prise, Stuart A. McIntosh, Manuel Salto-Tellez, Derek J. Richard, Christopher T. Elliott, D. Paul Harkin

PDF file - 124K

History

ARTICLE ABSTRACT

Germline mutations in BRCA1 predispose carriers to a high incidence of breast and ovarian cancers. BRCA1 functions to maintain genomic stability through critical roles in DNA repair, cell-cycle arrest, and transcriptional control. A major question has been why BRCA1 loss or mutation leads to tumors mainly in estrogen-regulated tissues, given that BRCA1 has essential functions in all cell types. Here, we report that estrogen and estrogen metabolites can cause DNA double-strand breaks (DSB) in estrogen receptor-α–negative breast cells and that BRCA1 is required to repair these DSBs to prevent metabolite-induced genomic instability. We found that BRCA1 also regulates estrogen metabolism and metabolite-mediated DNA damage by repressing the transcription of estrogen-metabolizing enzymes, such as CYP1A1, in breast cells. Finally, we used a knock-in human cell model with a heterozygous BRCA1 pathogenic mutation to show how BRCA1 haploinsufficiency affects these processes. Our findings provide pivotal new insights into why BRCA1 mutation drives the formation of tumors in estrogen-regulated tissues, despite the general role of BRCA1 in DNA repair in all cell types. Cancer Res; 74(10); 2773–84. ©2014 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC